Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Cerebrospinal fluid concentrations of N -acetylcysteine after oral administration: phase I trial in Parkinson's disease [abstract 664]
Their combined anti-inflammatory actions has been seen to create a more favorable environment for tissue repair
This corresponded with reduced eotaxin-2, CCR3, IL-13 and TNF- expression in the lung tissue, while Foxp3, IL-10 and TGF-1 levels were significantly upregulated [159]
+ Research Use Only (RUO) compound + Lyophilized powder format for convenient handling in laboratory settings + Not for human consumption + Not evaluated or approved by the FDA or any regulatory authority This product is intended solely for laboratory research and investigational purposes
US$ 28.55
US$ 22.52
US$ 24.15
US$ 25.84
